The interim final rule would amend
FDAs informed consent regulation to provide an exception to the
general requirement to obtain informed consent from the subject of
an investigation involving and unapproved or not cleared in vitro
diagnostic device intended to identify a chemical, biological,
radiological, or nuclear agent.
Statute at
Large: 21
Stat. 360 Name of Statute: null
The number of laboratories
(respondents) was changed (adjusted) to 150 laboratories that
perform this type testing. Thus this adjustment resulted in an
increase in the total burden estimate from 600 hours to 1350.
$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected
Saleda Perryman
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.